ArticleFrontiers in immunology2022

Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study.

Adrian M Shields et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.